中文名称：盐酸伊立替康三水合物
  • 盐酸依立替康三水合物; L-(+)-N-[4-[[(2,4-二氨基-6-蝶啶基)甲氨基]苯甲三水合物; 三水盐酸伊立替康; 盐酸三水伊立替康三水合物; 伊立替康盐酸盐三水合物; 盐酸伊立替康三水化合物; L-(+)-N-[4-[[(2,4-二氨基-6-蝶啶基)甲氨基]苯甲三水合物
  • Irinotecan hydrochloride trihydrate
  • (+)-7-Ethyl-10-hydroxycamptothecine 10-(1,4'-bipiperidine)-1'-carboxylate, monohydrochloride, trihydrate; Camptosar; Irinotecan HCl trihydrate; (1,4'-Bipiperidine)-1'-carboxylic acid, 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, monohydrochloride, trihydrate, (S)-; (1,4'-bipiperidine)-1'-carboxylicacid,4,11-diethyl-3,4,12,14-tetrahydro-4-hyd monohydrochloride, trihydrate; roxy-3,14-dioxo-1h-pyrano(3',4',6,7)indolizino(1,2-b)quinolin-9-ylester,mono; trihydrate,(s)-hydrochlorid trihydrate; irinotecan monohydrochloride trihydrate; [1,4'-bipiperidine]-1'-carboxylic acid (s)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano; [3',4',6,7]indolizino[1,2-b]quinolin-9-yl ester, hcl trihydrate; (s)-[1,4'-bipiperidine]-1'-carboxylic acid 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano; [3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride trihydrate; irinotecanhydrochloridetrihydrate(cpt-11); (19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate trihydrate hydrochloride; (+)-7-Ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin, monohydrochloride, trihydrate; (S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate hydrochloride trihydrate; (S)-[1,4'-Bipiperidine]-1'-carboxylic acid 4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester hydrochloride trihydrate; [1,4'-Bipiperidine]-1'-carboxylic acid,4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, monohydrochloride,trihydrate, (S)-; [1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester, hydrochloride, hydrate (1:1:3)
  • 136572-09-3
  • C33H39ClN4O6
  • 623.139
  • InChI=1/C33H38N4O6.ClH/c1-3-22-23-9-8-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)16-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2;/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3;1H/t33-;/m0./s1
  • 盐酸伊立替康三水合物 136572-09-3
  • 250-256℃ (dec.)
  • 主要用于治疗消化系统肿瘤如胃癌、结肠癌、直肠癌、肺癌等，也用于治疗白血病、葡萄胎和绒毛膜上皮癌。伊立替康是一种经过化学结构修饰的天然喜树碱的衍生物。它是疗效确切、毒副作用较小的新型抗癌药物，主要用于治疗肺癌、结直肠癌、胃癌、子宫癌、卵巢癌等癌症